Marketwise, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. has confirmed that future advisory votes on executive compensation will be held annually, following a decisive shareholder vote at the 2026 Annual Meeting.
NASDAQ
MKTW
Marketwise, INCMarketWise announced a 57% year-over-year increase in Q2 billings to $91.2 million and raised its full-year billings guidance by 10% to $330 million.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. stockholders elected a director and ratified auditors but rejected the advisory say-on-pay proposal.
NASDAQ
MKTW
Marketwise, INCMarketWise reported a Q1 2026 net loss of $0.6 million on $77.0 million in net revenue, but saw billings increase 15% year-over-year to $81.4 million, alongside a new $50 million stock repurchase program authorization.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. has entered into a settlement agreement with former CEO Mark P. Arnold to resolve ongoing litigation and arbitration.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced preliminary first quarter 2026 results, showing a return to paid subscriber growth and a 15% year-over-year increase in billings.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. reported strong FY2025 financial performance, surpassing guidance for Billings and Cash Flow From Operations, and outlined strategic priorities for continued growth in 2026.
NASDAQ
MKTW
Marketwise, INCMarketWise reports strong Q4 2025 results with a 42% year-over-year increase in Billings, beats FY 2025 guidance, and raises FY 2026 outlook while increasing dividends and resuming share buybacks.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced a 20% increase in its regular quarterly cash dividend and declared a special cash dividend, resulting in a 13% LTM dividend yield.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. reported preliminary unaudited Q4 2025 results, exceeding full-year guidance for both billings and cash flow from operations, with cash balances increasing to $70 million.
NASDAQ
MKTW
Marketwise, INCMarketWise's Special Committee has engaged Centerview Partners and Kirkland & Ellis to evaluate Monument & Cathedral Holdings' $17.25 per share acquisition proposal.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. reported strong third-quarter 2025 financial results, with a 30% year-over-year increase in Billings and a total FY 2025 dividend of $1.90 per Class A share, alongside preliminary FY 2026 targets.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced it received an unsolicited proposal from Monument & Cathedral Holdings, LLC to acquire all outstanding equity interests not owned by M&C for $17.25 per share in cash.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. reports robust second-quarter 2025 financial results, featuring increased adjusted billings, significant cash flow improvement, and a declared quarterly and special dividend.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced the appointment of Erik Mickels, current CFO, to the expanded role of Chief Operating and Financial Officer, effective July 31, 2025.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. stockholders have approved an amendment to the 2021 Incentive Award Plan, increasing the shares reserved for issuance by 1,630,554 shares.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced that its stockholders approved the election of two Class I directors, an amendment to increase shares under its 2021 Incentive Award Plan, and the ratification of Grant Thornton LLP as its independent auditor at the Annual Meeting held on June 12, 2025.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. has officially appointed Dr. David Eifrig as its permanent Chief Executive Officer, recognizing his leadership during his interim tenure which saw improved financial performance and a clear vision for the company's future.
NASDAQ
MKTW
Marketwise, INCMarketWise announced its Q1 2025 financial results, featuring a revenue decrease but a billings increase, along with the provision of full-year 2025 financial targets and a dividend announcement.
NASDAQ
MKTW
Marketwise, INCMarketWise Inc. reports a 26% sequential increase in preliminary Q1 2025 billings, initiates a share buyback program, and highlights a 16% LTM cash dividend yield.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. will implement a 1-for-20 reverse stock split effective April 2, 2025, to regain compliance with Nasdaq's minimum bid price requirement.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. stockholders approved a reverse stock split and a reduction in the number of authorized shares at a Special Meeting held on March 20, 2025.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announces the dismissal of Deloitte & Touche LLP and the appointment of Grant Thornton LLP as its new independent registered public accounting firm.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. reported a net income of $93.1 million and net revenue of $408.7 million for the full year 2024, and announced a stock repurchase program of up to $50 million.
NASDAQ
MKTW
Marketwise, INCMarketWise Inc. reports a significant increase in billings and a return to positive cash flow in Q4 2024, along with a special dividend of $0.03 per share.
NASDAQ
MKTW
Marketwise, INCMarketWise announced a net income of $22.7 million and net revenue of $97.2 million for the third quarter of 2024, alongside a decrease in paid subscribers and billings compared to the previous year.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. has received a notice from Nasdaq stating that its stock price has fallen below the minimum required level for continued listing.
NASDAQ
MKTW
Marketwise, INCMarketWise, Inc. announced the resignation of its Chief Operating Officer, Chad Curlett, effective August 19, 2024, with a separation agreement including a $100,000 payment.
NASDAQ
MKTW
Marketwise, INCMarketWise reported a net income of $21.2 million on $105.0 million in revenue for Q2 2024, while also announcing a leadership change and ongoing turnaround efforts.
NASDAQ
MKTW
Marketwise, INCMarketWise CEO and Chairman, F. Porter Stansberry, has resigned, effective immediately, following the termination of negotiations to acquire Porter & Co., with Dr. David Eifrig appointed as interim CEO and Matthew Turner as Acting Chairman.